Sandrock Joins Voyager As CEO To Advance New Gene Therapy Technology Into The Clinic
The former Biogen executive will succeed interim CEO Michael Higgins, who will continue as chairman.

The former Biogen executive will succeed interim CEO Michael Higgins, who will continue as chairman.